Cargando…
Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods
Background: Pancreatic cancer is diagnosed histologically through percutaneous biopsy (PB), endoscopic biopsy (EB), or surgical biopsy (SB). Factors and outcomes associated with method type are not clearly understood. We aimed to evaluate the relationship between insurance status, length of hospital...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306347/ https://www.ncbi.nlm.nih.gov/pubmed/37388621 http://dx.doi.org/10.7759/cureus.39660 |
_version_ | 1785065916257533952 |
---|---|
author | Mittal, Anmol Le, Alexander Kahlam, Aaron Haider, Syed F Prasath, Vishnu Khrais, Ayham Chokshi, Ravi |
author_facet | Mittal, Anmol Le, Alexander Kahlam, Aaron Haider, Syed F Prasath, Vishnu Khrais, Ayham Chokshi, Ravi |
author_sort | Mittal, Anmol |
collection | PubMed |
description | Background: Pancreatic cancer is diagnosed histologically through percutaneous biopsy (PB), endoscopic biopsy (EB), or surgical biopsy (SB). Factors and outcomes associated with method type are not clearly understood. We aimed to evaluate the relationship between insurance status, length of hospital stay (LOS), complications, and different pancreatic biopsy modalities. Study: The 2001-2013 database from the National (Nationwide) Inpatient Sample (NIS) was queried for those with pancreatic cancer who underwent biopsies using International Classification of Diseases, Ninth Revision (ICD-9) codes. Data regarding insurance status, hospital stay, demographics, and complications were analyzed using chi-square and multivariate analysis with α < 0.001. Results: A total of 824,162 patients with pancreatic cancer were identified. Uninsured and Medicaid patients were more likely to get PB compared to SB. Patients were more likely to have acute renal failure (ARF) with an EB compared to SB. Patients were more likely to have a urinary tract infection (UTI) with EB or PB compared to SB. All biopsy types were less likely to have pneumonia; pancreatitis was more prevalent in EB compared to PB and SB. Conclusions: Uninsured and Medicaid patients were most likely to have a PB compared to EB despite unclear indications which may represent an underlying discrepancy in healthcare utilization. EB patients had the shortest LOS while SB patients stayed three more days; those who underwent a combination of biopsies had the greatest LOS. Patients with EB were more likely to develop ARF, UTI, and pancreatitis than SB, possibly attributed to the advanced nature of endoscopic ultrasound. It is important to establish appropriate algorithm contributors to guide decision-making. |
format | Online Article Text |
id | pubmed-10306347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-103063472023-06-29 Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods Mittal, Anmol Le, Alexander Kahlam, Aaron Haider, Syed F Prasath, Vishnu Khrais, Ayham Chokshi, Ravi Cureus Internal Medicine Background: Pancreatic cancer is diagnosed histologically through percutaneous biopsy (PB), endoscopic biopsy (EB), or surgical biopsy (SB). Factors and outcomes associated with method type are not clearly understood. We aimed to evaluate the relationship between insurance status, length of hospital stay (LOS), complications, and different pancreatic biopsy modalities. Study: The 2001-2013 database from the National (Nationwide) Inpatient Sample (NIS) was queried for those with pancreatic cancer who underwent biopsies using International Classification of Diseases, Ninth Revision (ICD-9) codes. Data regarding insurance status, hospital stay, demographics, and complications were analyzed using chi-square and multivariate analysis with α < 0.001. Results: A total of 824,162 patients with pancreatic cancer were identified. Uninsured and Medicaid patients were more likely to get PB compared to SB. Patients were more likely to have acute renal failure (ARF) with an EB compared to SB. Patients were more likely to have a urinary tract infection (UTI) with EB or PB compared to SB. All biopsy types were less likely to have pneumonia; pancreatitis was more prevalent in EB compared to PB and SB. Conclusions: Uninsured and Medicaid patients were most likely to have a PB compared to EB despite unclear indications which may represent an underlying discrepancy in healthcare utilization. EB patients had the shortest LOS while SB patients stayed three more days; those who underwent a combination of biopsies had the greatest LOS. Patients with EB were more likely to develop ARF, UTI, and pancreatitis than SB, possibly attributed to the advanced nature of endoscopic ultrasound. It is important to establish appropriate algorithm contributors to guide decision-making. Cureus 2023-05-29 /pmc/articles/PMC10306347/ /pubmed/37388621 http://dx.doi.org/10.7759/cureus.39660 Text en Copyright © 2023, Mittal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Mittal, Anmol Le, Alexander Kahlam, Aaron Haider, Syed F Prasath, Vishnu Khrais, Ayham Chokshi, Ravi Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title | Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title_full | Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title_fullStr | Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title_full_unstemmed | Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title_short | Pancreatic Cancer Biopsy Modalities: Comparing Insurance Status, Length of Stay, and Hospital Complications Based on Percutaneous, Endoscopic, and Surgical Biopsy Methods |
title_sort | pancreatic cancer biopsy modalities: comparing insurance status, length of stay, and hospital complications based on percutaneous, endoscopic, and surgical biopsy methods |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306347/ https://www.ncbi.nlm.nih.gov/pubmed/37388621 http://dx.doi.org/10.7759/cureus.39660 |
work_keys_str_mv | AT mittalanmol pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT lealexander pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT kahlamaaron pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT haidersyedf pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT prasathvishnu pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT khraisayham pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods AT chokshiravi pancreaticcancerbiopsymodalitiescomparinginsurancestatuslengthofstayandhospitalcomplicationsbasedonpercutaneousendoscopicandsurgicalbiopsymethods |